7.80
1.56%
0.12
アフターアワーズ:
7.80
Sera Prognostics Inc (SERA) 最新ニュース
Rhumbline Advisers Makes New $190,000 Investment in Sera Prognostics, Inc. (NASDAQ:SERA) - Defense World
Bank of New York Mellon Corp Has $892,000 Holdings in Sera Prognostics, Inc. (NASDAQ:SERA) - Defense World
Sera Prognostics, Inc. (NASDAQ:SERA) Shares Sold by Resolute Capital Asset Partners LLC - Defense World
Sera Prognostics President Evguenia Lindgardt Sells 26% Of Holding - Simply Wall St
Ballentine Partners LLC Invests $294,000 in Sera Prognostics, Inc. (NASDAQ:SERA) - Defense World
Sera prognostics CFO sells over $38k in company stock - Investing.com India
Sera Prognostics CEO sells shares worth $189,893 - Investing.com
Sera prognostics CFO sells over $38k in company stock - Investing.com
Lake Street Advisors Group LLC Makes New $144,000 Investment in Sera Prognostics, Inc. (NASDAQ:SERA) - Defense World
Sera Prognostics director sells shares for tax obligations - Investing.com India
Sera Prognostics director sells shares for tax obligations - Investing.com
Sera Prognostics director sells shares for tax obligations By Investing.com - Investing.com Canada
Sera Prognostics director sells shares for tax obligations By Investing.com - Investing.com South Africa
Sera Prognostics (NASDAQ:SERA) Shares Up 0.4% - Defense World
Sera Prognostics to Present at H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Sera Prognostics to Present at H.C. Wainwright 26th Annual Global Investment Conference - Quantisnow
(SERA) Proactive Strategies - Stock Traders Daily
Sera Prognostics, Inc. (NASDAQ:SERA) Shares Sold by Vanguard Group Inc. - Defense World
John J. Boniface Sells 5,022 Shares of Sera Prognostics, Inc. (NASDAQ:SERA) Stock - Defense World
Austin Aerts Sells 6,760 Shares of Sera Prognostics, Inc. (NASDAQ:SERA) Stock - Defense World
Zhenya Lindgardt Sells 12,327 Shares of Sera Prognostics, Inc. (NASDAQ:SERA) Stock - Defense World
Sera Prognostics, Inc. (SERA) Q2 2024 Earnings Call Transcript - Seeking Alpha
Sera Prognostics to Participate in Panel Discussion at UBS Genomic Medicine Summit on August 14, 2024 - Kilgore News Herald
Sera Prognostics executive sells $37k in company stock - Investing.com India
Sera prognostics general counsel sells shares worth over $37k - Investing.com
Sera Prognostics CEO sells shares worth over $91k - Investing.com India
Sera Prognostics CIO sells over $37k in company stock - Investing.com
Sera Prognostics CEO sells shares worth over $91k - Investing.com
Sera Prognostics executive sells shares worth over $32,000 - Investing.com
Sera Prognostics CEO sells shares worth over $91k By Investing.com - Investing.com UK
Sera Prognostics executive sells $37k in company stock By Investing.com - Investing.com UK
Sera Prognostics to Participate in Panel Discussion at UBS Genomic Medicine Summit on August 14, 2024 - Longview News-Journal
Sera Prognostics to Participate in Panel Discussion at UBS Genomic Medicine Summit on August 14, 2024 - StockTitan
SERA Stock Earnings: Sera Prognostics Beats EPS, Misses Revenue for Q2 2024 - InvestorPlace
Sera Prognostics, Inc. (SERA) Reports Q2 Loss, Lags Revenue Estimates - MSN
Sera Prognostics, Inc. (SERA) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
SERA PROGNOSTICS REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS - The Herald Journal
Sera Prognostics (SERA) Set to Announce Quarterly Earnings on Wednesday - Defense World
Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2024 Financial Results on August 7, 2024 - The Herald Journal
Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2024 Financial Results on August 7, 2024 - Longview News-Journal
We're Not Worried About Sera Prognostics' (NASDAQ:SERA) Cash Burn - Simply Wall St
Commonwealth Equity Services LLC Trims Stake in Sera Prognostics, Inc. (NASDAQ:SERA) - Defense World
Sera Prognostics trial shows reduced preterm birth complications - Investing.com
Sera Prognostics trial shows reduced preterm birth complications By Investing.com - Investing.com India
Sera Prognostics PreTRM® Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial - Lelezard
Sera Prognostics PreTRM® Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial - Quantisnow
How To Trade (SERA) - Stock Traders Daily
Sera Prognostics added to Russell 2000 and 3000 indexes following conclusion of 2024 indexes annual reconstitution - Utah Business
Selling Buzz: Sera Prognostics Inc [SERA] Chief Executive Officer Lindgardt Zhenya sells 26,867 shares of the company - Knox Daily
Sera Prognostics trial shows reduced preterm birth complications By Investing.com - Investing.com
Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2022 Financial Results on May 10 - Quantisnow
Investor's Toolkit: Key Ratios for Assessing Sera Prognostics Inc (SERA)'s Performance – DWinneX - The Dwinnex
SERA PROGNOSTICS ADDED TO RUSSELL 2000 AND 3000 INDEXES FOLLOWING CONCLUSION OF 2024 ... - Longview News-Journal
Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2023 Financial Results on May ... - Quantisnow
Sera Prognostics Announces Pricing For PreTRM® Test, The Only Broadly Validated Blood Test To Assess Risk Of ... - Quantisnow
Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2024 Financial Results on May ... - Quantisnow
Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2023 Financial Results on ... - Quantisnow
Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2022 Financial Results ... - Quantisnow
Long Term Trading Analysis for (SERA) - Stock Traders Daily
Sera Prognostics Inc [SERA] Insider Activity: An Update for Investors – Knox Daily - Knox Daily
Teladoc (TDOC) Harnesses AI for Diabetes Care, Stock Rises 6.7% - Zacks Investment Research
Sera Prognostics trial shows reduced preterm birth complications By Investing.com - Investing.com South Africa
Elevance Health (ELV) Rallies 11.8% YTD: More Room to Run? - Zacks Investment Research
Sera Prognostics, Inc. (NASDAQ:SERA) most popular amongst individual investors who own 31% of the shares ... - Yahoo Finance
Sera Prognostics, Inc. (NASDAQ:SERA) most popular amongst individual investors who own 31% of the shares, institutions hold 29% - Yahoo Finance
Citigroup analysts downgrades a Neutral rating for Sera Prognostics Inc (SERA) – Knox Daily - Knox Daily
Post-Trade Analysis: Sera Prognostics Inc (SERA) Slides -3.32, Closing at 7.27 – DWinneX - The Dwinnex
3 Stocks Under $10 With the Potential to Make You a Millionaire - InvestorPlace
大文字化:
|
ボリューム (24 時間):